相关实验视频

Updated: Jun 18, 2025

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

Published on: April 28, 2022

慢性腹腔透析患者的SGLT-2抑制剂:一个后续研究

Jia-Wen Lai¹, Charles C N Wang², Che-Yi Chou^3,4,5,6

¹Division of Nephrology, Asia University Hospital, Taichung, Taiwan.

|July 29, 2024

概括

-葡萄糖载体-2 抑制剂 (SGLT-2i) 可能改善腹腔透析 (PD) 患者的超过和血红蛋白. 这项研究没有发现尿路感染的增加,但注意到与亚临床代谢性酸性疾病的联系.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
内分泌学在内分泌学.
心脏病学心脏病学

背景情况:

建议使用-葡萄糖转运体-2 抑制剂 (SGLT-2i) 治疗心血管或脏疾病的2 型糖尿病患者.
关于在透析患者中使用SGLT-2i的数据有限.
这项研究研究了慢性腹膜透析 (PD) 患者的SGLT-2i.

研究的目的:

评估使用SGLT-2i的慢性PD患者的临床特征和结果.
为了比较超过,HbA1c,尿路感染 (UTI) 情节,以及有或没有SGLT-2i的PD患者之间的静脉CO2水平.

主要方法:

一个观察性,追溯的后续研究.
招募了50名糖尿病慢性PD患者,11名继续SGLT-2i.
在SGLT-2i用户和非用户之间比较超,HbA1c,UTI和静脉CO2.

主要成果:

使用SGLT-2i的患者的超过率 (1322比985毫升/天) 和血红蛋白水平 (11.2比10.2g/dl) 显著提高.
在SGLT-2i用户中,白细胞计数较高,静脉CO2较低.
在尿量,整体存活率,技术存活率或尿路感染率方面没有发现显著差异.

结论:

在慢性PD患者中,SGLT-2i可能会增强超和血红蛋白.
使用SGLT-2i并没有增加尿路感染风险.
观察到SGLT-2i与亚临床代谢性酸性疾病之间的潜在联系.

关键词:

腹膜透析是指腹膜透析.在SGLT-2中使用.超过的过方法

更多相关视频

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

相关概念视频

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: